Press Releases

TB Alliance Applauds Actions by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New

The TB Alliance announced on May 25 that it is receiving $104 million from the Bill & Melinda Gates Foundation

Three Grants Announced at Columbia University Symposium Tracking Progress in Battle Against Disease Infecting One-Third of the World NEW YORK

Project Aims to Streamline and Shorten Drug Development for Tuberculosis New York, NY and Waltham, MA., February 21, 2006 –

At its October 2005 Board Meeting, the TB Alliance Board of Directors appointed two new Board members to three-year terms:

Bayer Healthcare AG has signed an agreement with the Global Alliance for TB Drug Development to study whether the quinolone

NEW YORK CITY (July 5, 2005) — The TB Alliance announced the appointment of Ms. Nina Schwalbe as Director of

Trial is First in TB Alliance’s Growing Pipeline of Drugs — Provides Model for Future Drug Development NEW YORK CITY

Program Commits to Affordable Pricing New York/London – March 21, 2005 – The Global Alliance for TB Drug Development (TB

New York/Amsterdam – February 3, 2005 – The Department of Development Cooperation of the Netherlands Ministry of Foreign Affairs (DGIS),